A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: AUTO1

Sponsor

Autolus Limited